Skip to main content
Richard Joseph Jr., MD, Oncology, Jacksonville, FL

RichardWJosephJr.MD

Oncology • Jacksonville, FL

Genitourinary Oncology, Hematologic Oncology, Melanoma

Senior Medical Director Daiichi Sankyo

Join to view full profile

Dr. Joseph is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Joseph's full profile

Already have an account?

  • Office

    4500 San Pablo Rd S
    Jacksonville, FL 32224
    Phone+1 904-953-2000
    Fax+1 888-978-4098

Summary

  • I am a medical oncologist working in Drug Development for Daiichi Sankyo.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
  • Emory University School of Medicine
    Emory University School of MedicineClass of 2004

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - Present
  • FL State Medical License
    FL State Medical License 2011 - 2025
  • TX State Medical License
    TX State Medical License 2007 - 2011
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • AACR Career Development Award AACR, 2012
  • ASCO Young Investigator Award ASCO, 2009

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Publisher Correction: Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell Ca...  
    Michael B Atkins, Mario Sznol, Robert J Motzer, Richard W Joseph, Thomas Hutson, John Hainsworth, W Kimryn Rathmell, Brian I Rini, David F McDermott, Toni K Choueiri, ..., Nature
  • Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell Carcinoma  
    Michael B Atkins, Thomas Hutson, Mario Sznol, Toni K Choueiri, Sumanta K Pal, Richard W Joseph, John Hainsworth, W Kimryn Rathmell, David F McDermott, Robert J Motzer,..., Nature

Lectures

  • Health-related quality of life (HRQoL) in patients with advanced melanoma receiving immunotherapies across real-world clinical practice settings. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Health care resource utilization in patients with advanced melanoma receiving immunotherapies in the real world. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Pembrolizumab May Help Prevent Early-Stage Melanoma from Returning
    Pembrolizumab May Help Prevent Early-Stage Melanoma from ReturningOctober 13th, 2021
  • Presents State of the Science Summit™ on Genitourinary Cancers
    Presents State of the Science Summit™ on Genitourinary CancersJuly 23rd, 2019
  • Immunotherapy Highly Effective in Treatment of Rare Skin Cancer, Study Finds
    Immunotherapy Highly Effective in Treatment of Rare Skin Cancer, Study FindsJanuary 10th, 2018
  • Join now to see all

Professional Memberships

Dr. Richard Joseph, Dr. Richard Joseph, MD, Dr. R Joseph, Dr. Richard W Joseph